Market Overview:
The global flunixin meglumine injection market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for flunixin meglumine injection due to its various benefits such as analgesic, anti-inflammatory, and antipyretic properties. In addition, the growing awareness about animal health and rising disposable income are also contributing factors for the growth of this market. Based on type, the global flunixin meglumine injection market can be segmented into 10ml/dose and 20ml/dose segments. The 10ml/dose segment is expected to account for a larger share of the global market than the 20ml/dose segment during the forecast period owing to its lower price point and easy availability. Based on application,the global flunixin meglumine injectionmarket can be divided into three segments: animal muscle pain, animal febrile disease, and others (which includes conditions such as mastitis).
Product Definition:
Flunixin Meglumine Injection is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation in horses. It is also used to reduce the risk of laminitis (a hoof disorder) in horses at high risk for the condition.
10ml/Dose:
10ml/Dose, it's usage and growth factor in Flunixin Meglumine Injection market? 10 ml/dose is the standard concentration for veterinary medicine. It is used to treat bacterial skin infections in dogs and cats. The medicine works by killing the bacteria that causes infection.
20ml/ Dose:
20ml/dose is a sterile solution containing 10 mg/ ml Flunixin Meglumine. It is used for the treatment of dogs with flea and tick infestations. 20ml/ dose can be administered to animals weighing more than 5 kg as well as to puppies below the age of 3 months.
Application Insights:
The animal muscle pain segment held the largest share of over 40.0% in 2017. Flunixin meglumine injection is used for treating musculoskeletal disorders in animals due to its anti-inflammatory and analgesic properties. These injections are highly effective for acute as well as chronic conditions, which makes it a popular choice among veterinarians across the world.
Animal febrile disease accounted for a significant market share in terms of revenue generation in 2017 owing to increasing incidence rate of this condition among animals worldwide, especially dogs and cats suffering from colds or flu infection. The drug is used to treat bacterial infections caused by various other microorganisms such as Escherichia coli (E Coli), Staphylococcus Aureus (S Aureus) and Streptococcus pneumoniae (Pneumonia).
Regional Analysis:
North America was the largest regional market in 2017 owing to high animal population and increasing pet adoption. According to a survey conducted by the American Pet Products Association (APPA), in U.S., around 68% of households owned at least one pet as of 2018, which is an all-time high and this trend is projected to continue over the forecast period. Increasing prevalence of chronic diseases has led veterinarians across North America to increase their revenue from veterinary services by 7% annually between 2010 and 2015, reaching nearly USD X billion industry size.
Growth Factors:
- Increasing demand for meat and meat products is expected to drive the growth of the flunixin meglumine injection market.
- Rising awareness about animal health and increasing adoption of preventive healthcare measures are also expected to fuel the growth of this market in the coming years.
- Growing demand for veterinary drugs and rising investments by key players in research and development are anticipated to boost the growth of this market in the near future.
- The increasing prevalence of livestock diseases is projected to create lucrative opportunities for players operating in this market over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Flunixin Meglumine Injection Market Research Report
By Type
10ml/Dose, 20ml/ Dose
By Application
Animal muscle pain, Animal febrile disease, Others
By Companies
Norbrook, Zoteis, Merck Animal Health, Virbac Animal Health India Private Limited, MSD Animal Health, Bengal Remedies Limited, Wuhan Huisheng Biological Technology Co., Ltd., Qilu Animal Health Products Co., Ltd., Baimukang Animal Pharmaceutical Co., Ltd., Shandong Zhongmu Veterinary Medicine Co., Ltd., Hebei New Century Pharmaceutical Co., Ltd., Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd., Shandong Lukang Pharmaceutical Co., Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
185
Number of Tables & Figures
130
Customization Available
Yes, the report can be customized as per your need.
Global Flunixin Meglumine Injection Market Report Segments:
The global Flunixin Meglumine Injection market is segmented on the basis of:
Types
10ml/Dose, 20ml/ Dose
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Animal muscle pain, Animal febrile disease, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Norbrook
- Zoteis
- Merck Animal Health
- Virbac Animal Health India Private Limited
- MSD Animal Health
- Bengal Remedies Limited
- Wuhan Huisheng Biological Technology Co., Ltd.
- Qilu Animal Health Products Co., Ltd.
- Baimukang Animal Pharmaceutical Co., Ltd.
- Shandong Zhongmu Veterinary Medicine Co., Ltd.
- Hebei New Century Pharmaceutical Co., Ltd.
- Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
- Shandong Lukang Pharmaceutical Co., Ltd.
Highlights of The Flunixin Meglumine Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 10ml/Dose
- 20ml/ Dose
- By Application:
- Animal muscle pain
- Animal febrile disease
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Flunixin Meglumine Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Flunixin Meglumine Injection is a medication used to treat pain and inflammation. It is a corticosteroid, meaning it works by reducing inflammation. Flunixin Meglumine Injection is available in a liquid form and can be injected into the muscle or vein.
Some of the key players operating in the flunixin meglumine injection market are Norbrook, Zoteis, Merck Animal Health, Virbac Animal Health India Private Limited, MSD Animal Health, Bengal Remedies Limited, Wuhan Huisheng Biological Technology Co., Ltd., Qilu Animal Health Products Co., Ltd., Baimukang Animal Pharmaceutical Co., Ltd., Shandong Zhongmu Veterinary Medicine Co., Ltd., Hebei New Century Pharmaceutical Co., Ltd., Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd., Shandong Lukang Pharmaceutical Co., Ltd..
The flunixin meglumine injection market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Flunixin Meglumine Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Flunixin Meglumine Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Flunixin Meglumine Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Flunixin Meglumine Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Flunixin Meglumine Injection Market Size & Forecast, 2020-2028
4.5.1 Flunixin Meglumine Injection Market Size and Y-o-Y Growth
4.5.2 Flunixin Meglumine Injection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 10ml/Dose
5.2.2 20ml/ Dose
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Animal muscle pain
6.2.2 Animal febrile disease
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Flunixin Meglumine Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Flunixin Meglumine Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 10ml/Dose
9.6.2 20ml/ Dose
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Animal muscle pain
9.10.2 Animal febrile disease
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 10ml/Dose
10.6.2 20ml/ Dose
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Animal muscle pain
10.10.2 Animal febrile disease
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 10ml/Dose
11.6.2 20ml/ Dose
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Animal muscle pain
11.10.2 Animal febrile disease
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 10ml/Dose
12.6.2 20ml/ Dose
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Animal muscle pain
12.10.2 Animal febrile disease
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 10ml/Dose
13.6.2 20ml/ Dose
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Animal muscle pain
13.10.2 Animal febrile disease
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Flunixin Meglumine Injection Market: Competitive Dashboard
14.2 Global Flunixin Meglumine Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Norbrook
14.3.2 Zoteis
14.3.3 Merck Animal Health
14.3.4 Virbac Animal Health India Private Limited
14.3.5 MSD Animal Health
14.3.6 Bengal Remedies Limited
14.3.7 Wuhan Huisheng Biological Technology Co., Ltd.
14.3.8 Qilu Animal Health Products Co., Ltd.
14.3.9 Baimukang Animal Pharmaceutical Co., Ltd.
14.3.10 Shandong Zhongmu Veterinary Medicine Co., Ltd.
14.3.11 Hebei New Century Pharmaceutical Co., Ltd.
14.3.12 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
14.3.13 Shandong Lukang Pharmaceutical Co., Ltd.
